Try our new research platform with insights from 80,000+ expert users

Centrify Privilege Threat Analytics Service vs Citrix Analytics for Security [EOL] comparison

 

Comparison Buyer's Guide

Executive Summary

Review summaries and opinions

We asked business professionals to review the solutions they use. Here are some excerpts of what they said:
 

Categories and Ranking

Centrify Privilege Threat A...
Average Rating
0.0
Number of Reviews
0
Ranking in other categories
User Entity Behavior Analytics (UEBA) (30th)
Citrix Analytics for Securi...
Average Rating
8.0
Number of Reviews
2
Ranking in other categories
No ranking in other categories
 

Featured Reviews

Use Centrify Privilege Threat Analytics Service?
Share your opinion
Federico_Villanueva - PeerSpot reviewer
Helped the organization to provide high-security access to applications and performs well
From the point of view of a user, it is a scalable solution. The solution performs well with growth and is easily accessible. There are less than one hundred users because it's part of a SIP company. But in the main group, it has three thousand users. The idea is to grow and provide our service to two thousand users.
report
Use our free recommendation engine to learn which User Entity Behavior Analytics (UEBA) solutions are best for your needs.
861,170 professionals have used our research since 2012.
 

Questions from the Community

Ask a question
Earn 20 points
What is your experience regarding pricing and costs for Citrix Analytics?
The solution is fairly priced. There are no additional costs involved, one only needs to pay the licensing cost.
What needs improvement with Citrix Analytics?
The remote access features need improvement.
 

Also Known As

Centrify Analytics Services
Citrix Analytics for Performance
 

Overview

 

Sample Customers

GSI
Scripps Health, Sydney University, Element Six, Lindex, SAS
Find out what your peers are saying about IBM, Exabeam, Cynet and others in User Entity Behavior Analytics (UEBA). Updated: June 2025.
861,170 professionals have used our research since 2012.